Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Hypersensitivity Reaction

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 46 articles:
HTML format



Single Articles


    February 2024
  1. LONGHURST HJ, Lindsay K, Petersen RS, Fijen LM, et al
    CRISPR-Cas9 In Vivo Gene Editing of KLKB1 for Hereditary Angioedema.
    N Engl J Med. 2024;390:432-441.
    PubMed     Abstract available


    November 2023
  2. MOSNAIM G
    Asthma in Adults. Reply.
    N Engl J Med. 2023;389:10.
    PubMed    


  3. BELL KJL, Kazda L, Parker G
    Asthma in Adults.
    N Engl J Med. 2023;389:10.
    PubMed    


  4. RABIN AS, Junck L, Shankar HM
    Asthma in Adults.
    N Engl J Med. 2023;389:10.
    PubMed    


  5. SELINGER S
    Asthma in Adults.
    N Engl J Med. 2023;389:10.
    PubMed    


  6. WONG JCY, Li PH
    Large-Bowel Obstruction from Hereditary Angioedema.
    N Engl J Med. 2023;389:e41.
    PubMed    


    October 2023
  7. KWATRA SG, Yosipovitch G, Legat FJ, Reich A, et al
    Phase 3 Trial of Nemolizumab in Patients with Prurigo Nodularis.
    N Engl J Med. 2023;389:1579-1589.
    PubMed     Abstract available


  8. JANUSONYTE E, Punchera J
    Shiitake Dermatitis.
    N Engl J Med. 2023;389:1415.
    PubMed    


    September 2023
  9. MOSNAIM G
    Asthma in Adults.
    N Engl J Med. 2023;389:1023-1031.
    PubMed    


    July 2023
  10. AGUSTI A
    Biologics for COPD - Finally Here.
    N Engl J Med. 2023;389:274-275.
    PubMed    


  11. WOLKOW N, Romo LV, Edwards CV, Stagner AM, et al
    Case 21-2023: A 61-Year-Old Man with Eyelid Swelling.
    N Engl J Med. 2023;389:166-175.
    PubMed    


    June 2023
  12. SILVERBERG JI, Guttman-Yassky E, Gontijo Lima R
    Lebrikizumab for Moderate-to-Severe Atopic Dermatitis. Reply.
    N Engl J Med. 2023;388:2299-2300.
    PubMed    


  13. SMITH B, Engel P, Wu JJ
    Lebrikizumab for Moderate-to-Severe Atopic Dermatitis.
    N Engl J Med. 2023;388:2299.
    PubMed    


    May 2023
  14. TOGIAS A
    Good News for Toddlers with Peanut Allergy.
    N Engl J Med. 2023;388:1814-1815.
    PubMed    


  15. GREENHAWT M, Sindher SB, Wang J, O'Sullivan M, et al
    Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy.
    N Engl J Med. 2023;388:1755-1766.
    PubMed     Abstract available


    April 2023
  16. CONNOLLY CM, Christopher-Stine L
    Periorbital Edema in Dermatomyositis.
    N Engl J Med. 2023;388:e52.
    PubMed    


    March 2023
  17. SILVERBERG JI, Guttman-Yassky E, Thaci D, Irvine AD, et al
    Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis.
    N Engl J Med. 2023 Mar 15. doi: 10.1056/NEJMoa2206714.
    PubMed     Abstract available


  18. DELLON ES, Rothenberg ME, Bredenoord AJ
    Dupilumab in Patients with Eosinophilic Esophagitis. Reply.
    N Engl J Med. 2023;388:956-957.
    PubMed    


  19. GREUTER T, Schoepfer AM
    Dupilumab in Patients with Eosinophilic Esophagitis.
    N Engl J Med. 2023;388:955-956.
    PubMed    


    January 2023
  20. KAKURAI M, Oya K
    Atopic Eruption of Pregnancy.
    N Engl J Med. 2023;388:357.
    PubMed    


    December 2022
  21. STRAUMANN A
    Biologics in Eosinophilic Esophagitis - Ready for Prime Time?
    N Engl J Med. 2022;387:2379-2380.
    PubMed    


  22. DELLON ES, Rothenberg ME, Collins MH, Hirano I, et al
    Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis.
    N Engl J Med. 2022;387:2317-2330.
    PubMed     Abstract available


  23. LANG DM
    Chronic Urticaria. Reply.
    N Engl J Med. 2022;387:2103.
    PubMed    


  24. ROLLA G
    Chronic Urticaria.
    N Engl J Med. 2022;387:2102-2103.
    PubMed    


  25. WEINBERGER M
    Chronic Urticaria.
    N Engl J Med. 2022;387:2102.
    PubMed    


  26. BONNIN AJ
    Chronic Urticaria.
    N Engl J Med. 2022;387:2101-2102.
    PubMed    


  27. DESCAMPS V
    Chronic Urticaria.
    N Engl J Med. 2022;387:2101.
    PubMed    


    September 2022
  28. LANG DM
    Chronic Urticaria.
    N Engl J Med. 2022;387:824-831.
    PubMed    


    August 2022
  29. PAPI A, Chipps BE, Cappelletti C
    Albuterol-Budesonide Fixed-Dose Combination Rescue Inhaler for Asthma. Reply.
    N Engl J Med. 2022;387:663.
    PubMed    


  30. LIPWORTH BJ, Chan R, Stewart KE
    Albuterol-Budesonide Fixed-Dose Combination Rescue Inhaler for Asthma.
    N Engl J Med. 2022;387:662-663.
    PubMed    


    July 2022
  31. HUNG WK, Chung WH
    Drug Reaction with Eosinophilia and Systemic Symptoms.
    N Engl J Med. 2022;387:167.
    PubMed    


    June 2022
  32. SCHATZ M
    Another Rescue Therapy Option for Patients with Moderate-to-Severe Asthma.
    N Engl J Med. 2022;386:2139-2140.
    PubMed    


    May 2022
  33. PAPI A, Chipps BE, Beasley R, Panettieri RA Jr, et al
    Albuterol-Budesonide Fixed-Dose Combination Rescue Inhaler for Asthma.
    N Engl J Med. 2022 May 15. doi: 10.1056/NEJMoa2203163.
    PubMed     Abstract available


    April 2022
  34. BRYANT-STEPHENS T
    Breaking the Skin Color Barriers for Asthma Medications - It's Not Black, Brown, or White.
    N Engl J Med. 2022;386:1574-1575.
    PubMed    


    March 2022
  35. LONGHURST HJ, Ameratunga R
    An Antisense Oligonucleotide for Hereditary Angioedema.
    N Engl J Med. 2022;386:1083-1085.
    PubMed    


  36. BANERJI A, Phadke NA, Gottumukkala R, Sharma R, et al
    Case 8-2022: A 54-Year-Old Woman with Episodes of Swelling.
    N Engl J Med. 2022;386:1071-1079.
    PubMed    


  37. FIJEN LM, Riedl MA, Bordone L, Bernstein JA, et al
    Inhibition of Prekallikrein for Hereditary Angioedema.
    N Engl J Med. 2022;386:1026-1033.
    PubMed     Abstract available


    February 2022
  38. ISRAEL E, Cardet JC, Carroll JK, Fuhlbrigge AL, et al
    Reliever-Triggered Inhaled Glucocorticoid in Black and Latinx Adults with Asthma.
    N Engl J Med. 2022 Feb 26. doi: 10.1056/NEJMoa2118813.
    PubMed     Abstract available


    January 2022
  39. BRUSSELLE GG, Koppelman GH
    Biologic Therapies for Severe Asthma.
    N Engl J Med. 2022;386:157-171.
    PubMed    


    December 2021
  40. GONZALEZ BURCHARD E, Borrell LN
    Need for Racial and Ethnic Diversity in Asthma Precision Medicine.
    N Engl J Med. 2021;385:2297-2298.
    PubMed    


  41. BACHARIER LB, Maspero JF, Katelaris CH, Fiocchi AG, et al
    Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma.
    N Engl J Med. 2021;385:2230-2240.
    PubMed     Abstract available


  42. ZHANG B, Ma L
    Transverse Nasal Creases.
    N Engl J Med. 2021;385:2281.
    PubMed    


    October 2021
  43. BARDIN PG, Foster PS
    Clinical Translation of Basic Science in Asthma.
    N Engl J Med. 2021;385:1714-1717.
    PubMed    


  44. ASKENASE PW
    Rare Skin Reactions after mRNA Vaccination, Similar to Jones-Mote Basophil Responses.
    N Engl J Med. 2021;385:1720-1721.
    PubMed    


  45. BRIGHTLING CE, Nair P, Cousins DJ, Louis R, et al
    Risankizumab in Severe Asthma - A Phase 2a, Placebo-Controlled Trial.
    N Engl J Med. 2021;385:1669-1679.
    PubMed     Abstract available


  46. WECHSLER ME, Ruddy MK, Pavord ID, Israel E, et al
    Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma.
    N Engl J Med. 2021;385:1656-1668.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hypersensitivity Reaction is free of charge.